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Premature birth, respiratory distress, intracerebral hemorrhage,
and silvery-gray hair: differential diagnosis of the 3 types of
Griscelli syndrome
Abstract
A preterm neonate, born to consanguineous parents, presented with respiratory distress, intracerebral
hemorrhage, and a silvery-gray sheen of the hair and eyelashes. Griscelli syndrome (GS) type 3 was
diagnosed after the detection of a novel homozygous mutation of the melanophilin gene. Thus, only the
hypopigmentation, but not the patient's other clinical features, were attributable to this form of GS.
Differential diagnosis of the various forms of GS must be performed as early as possible as GS2 is
associated with a life threatening but curable immune disorder.
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Abstract 
A preterm neonate, born to consanguineous parents, presented with respiratory 
distress, intracerebral hemorrhage and a silvery-gray sheen of the hair and eyelashes. 
Griscelli syndrome (GS) type 3 was diagnosed following the detection of a novel 
homozygous mutation of the melanophilin gene. Thus, only the hypopigmentation, but 
not the patient’s other clinical features, were attributable to this form of GS. Differential 
diagnosis of the various forms of GS must be performed as early as possible since GS2 is 
associated with a life-threatening but curable immune disorder. 
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Introduction 
Griscelli syndrome (GS) is a rare autosomal recessive disorder characterized by 
hypopigmentation of the skin and hair, the presence of large clumps of pigment in hair 
shafts and an accumulation of mature melanosomes within the melanocytes (1). These 
pigmentary features are specific for patients with GS and can be distinguished from the 
hypopigmentation observed in other disorders such as Chediak-Higashi and Hermansky-
Pudlak syndromes. Griscelli syndrome was first described as the combination of an 
immune disorder to this hypopigmentation. Most GS patients develop an uncontrolled T 
lymphocyte and macrophage activation syndrome (known as the “accelerated phase” or 
hemophagocytic syndrome) which may lead to secondary neurological impairment. In 
contrast, other patients develop a primary severe neurological impairment in the absence 
of apparent immune abnormalities. Defects in two different genes, MYO5A and RAB27A, 
are thought to be responsible for GS type 1 and 2 (GS1 and GS2) phenotypes, 
respectively (2, 3). 
 
In GS1 the characteristic hypopigmentation is combined with a severe primary 
neurological impairment which arises early in life. These patients carry mutations in the 
myosin 5A gene (MYO5A), which encodes an organelle motor protein (myosin Va) with a 
critical role in neuron function. In contrast, hypopigmentation in GS2 is associated with 
an immune disorder which leads to episodes of hemophagocytic syndrome with activated 
T cells and macrophages infiltrating various organs (including the brain) and causing 
massive tissue damage, organ failure, pancytopenia and (in the absence of 
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immunosuppressive treatment) death. Bone marrow transplantation is the only curative 
treatment for this condition. Griscelli syndrome type 2, caused by mutations in the 
RAB27A gene encoding a small GTPase protein (Rab27a) involved a vesicular secretory 
pathway. The immune deregulation observed in GS2 patients results from the absolute 
requirement for functional Rab27a in lymphocyte cytotoxic granule release and the 
critical role of this cytotoxic pathway in lymphocyte homeostasis. The MYO5A and 
RAB27A genes both map to the same chromosomal region (15q21.1). More recently, a 
third form of GS (type 3, GS3) was shown to result from a melanophilin defect. In this 
genetic form, the phenotype is restricted to the hypopigmentation that is characteristic of 
GS. Melanophilin is an effector of Rab27a in melanocytes. The Rab27a protein targets 
the melanosome membrane and binds to melanophilin. Melanophilin then recruits the 
molecular motor myosin Va, which allows movement or tethering of the melanosomes on 
the actin cytoskeleton. The tripartite myosin Va-melanophilin-Rab27a complex drives 
mature melanosomes to the dendritic tips of melanocytes and thus enables delivery of the 
melanin to adjacent keratinocytes. These findings explain the common pigmentary 
features observed in GS1, GS2, and GS3 patients whose distinct characteristics (listed in 
Fig. 1A) are partly due to tissue-specific expression of the corresponding genes. Although 
all three proteins are expressed in melanocytes, only myosin Va is expressed in neurons 
and only Rab27a is expressed in cytotoxic lymphocytes.  
 
Here, we report on a preterm neonate with GS-typical hypopigmentation and who 
presented with respiratory distress and intracerebral hemorrhage. A mutation in the 
melanophilin gene was found and so GS3 was diagnosed. Since GS3 is restricted to 
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hypopigmentation, no treatment was needed. The preterm delivery, respiratory distress 
and intracerebral hemorrhage were not attributable to hemophagocytic syndrome and 
were unrelated to GS3. 
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Patient presentation 
We report on a Saudi-Arabian boy, now aged 19 months. He was born to 
consanguineous healthy parents (first degree cousins). There was no history of childhood 
death or suspected immunodeficiency in the family. Due to premature rupture of the fetal 
membranes, the neonate was delivered after 30 weeks of gestation. The weight was 1010 
g (10th percentile for gestational age), length 38 cm (10th percentile) and head 
circumference 26 cm (just below the 10th percentile). Due to infant respiratory distress 
syndrome, the baby was taken to a neonatal intensive care unit and received mechanical 
ventilation for 58 days. A grade II intraventricular, cerebral hemorrhage and a grade IV 
hematoma (both on the left hand side) were diagnosed by ultrasonography at the 
chronological age of 9 days. Hemostatic plasma parameters and blood cell counts were 
normal. The patient did not have fever, lymphadenopathy or hepatosplenomegaly. 
Regularly performed neurological assessments showed normal muscle tone, gross motor 
activities and cognitive functions. A computed tomography (CT) scan of the brain at the 
age of 7 months showed no shift of the brain midline structures and no signs of recent 
intracranial hemorrhage. There was evidence of mild lateral ventricle asymmetry that 
could have resulted from the previous hemorrhage. At the chronological age of 10 
months, the child had a developmental age of 8 months. 
 
The boy had silvery-gray hair and fair skin as shown in Figure 1 B. He was 
admitted to the Immunology department for suspected GS. Light microscopy 
examination of his hair showed large clumps of pigment irregularly distributed along the 
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hair shaft (Fig. 1 C). There were no episodes suggestive of hemophagocytic syndrome. 
Segregation of microsatellite markers in the family excluded the RAB27A/MYO5A locus 
but was compatible with the MLHP locus. Genomic DNA sequencing revealed a novel, 
homozygous mutation in MLHP exon 7 (delC986) leading to a frame shift and L344X 
(Figure 2 A). Both parents were heterozygous. The L344 residue is located in the myosin-
binding domain of melanophilin (Figure 2 B).  
 
Informed consent for the present study and publication of the photographs were 
been obtained from the child's parents and the work was approved by the local 
independent ethics committee. 
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Discussion 
Here, we report on a boy with a new homozygous mutation in the melanophilin 
gene which resulted in GS3, where the GS phenotype is limited to hypopigmentation. 
This is the second case of GS3 reported. Our preterm born patient had GS-characteristic 
hypopigmentation, was suffering from infant respiratory distress syndrome and had 
radiological signs of intraventricular hemorrhage. He recovered from the respiratory 
distress and did not show any neurological sequelae at the age of 8 months. Characteristic 
hypopigmentation is a shared feature in individuals with GS1, GS2, and GS3. In GS1, 
hypopigmentation is combined with a severe neurological impairment and muscle 
hypotonia at onset. Primary mental retardation and regressive neurological disorders have 
been described (4). The child described here did not show any of these clinical signs and 
his mental development was normal.  
 
Griscelli syndrome type 2 is associated with an immune disease which results in episodes 
of a life-threatening hemophagocytic syndrome that necessitate treatment with 
immunosuppressive agents. In GS2, the age at the first episode of hemophagocytic 
syndrome varies. Hemophagocytic syndromes can occur in the neonatal period and may 
be associated with preterm delivery (5). Thus, GS2-associated hemophagocytic syndrome 
represents an important differential diagnosis in a the patient with GS-characteristic 
hypopigmentation, preterm delivery, respiratory distress and intraventricular hemorrhage, 
such as the case reported here. It is clear that prematurity per se is not related to GS1 or 
GS3; however, it can be associated with hemophagocytosis and thus GS2. 
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In GS2, the only curative treatment for the immune disease is hematopoietic stem 
cell transplantation. Early diagnosis and transplantation are essential for a positive 
outcome in GS2 patients and it has been suggested that pre-emptive transplantation, i.e. 
before the occurrence of the hemophagocytic syndrome should be preferred. We 
diagnosed GS3 in the patient presented here. Preterm delivery, distress and 
intraventricular hemorrhage were not associated with a hemophagocytic syndrome. 
Hence, neither immunosuppressive treatment nor hematopoietic transplantation was 
indicated in this patient. Hemophagocytosis is characterized by unremitting polyclonal 
CD8 T cell activation and is associated with genetic defects in cytotoxicity. The 
pathogenesis of hemophagocytosis is based on the cytotoxic effector cells’ inability to 
kill the antigen presenting cells and thus eliminate the infecting pathogens. Persistence of 
the trigger probably induces an unremitting polyclonal CD8 T cell activation. It has been 
shown, that the gene product of melanophilin is not detectable in cytotoxic T 
lymphocytes (in contrast to melanocytes). Therefore, a melanophilin deficiency will not 
affectthe T lymphocytes’ cytotoxic machinery. This is why the child presented in this 
report does not have an greater risk of developing hemophagocytosis than a healthy child 
lacking the underlying genetic defect. This view is further supported by the fact that the 
proband with melanophilin deficiency reported previously is now 21 and has not 
experienced any hemophagocytosis. Additionally, no hemophagocytosis has occurred in 
our own, unpublished cohort of 3 further individuals with melanophilin deficiency 
(current ages - patient 1: 19 years, patient 2: 7.6 years, patient 3: 4 years).  
 
10 
We hope that the present case report will draw the attention to GS, since although GS2 is 
associated with a life-threatening and potentially curable immune disorder, GS1 and GS3 
do not require hematopoietic stem cell transplantation. General pediatricians are not very 
familiar with GS. Although the syndrome is rare, silvery hair sheen is easy to recognize. 
Hence, recognition of this feature by the general pediatrician and referral to a pediatric 
immunologist could improve life expectancy and quality of life for patients suffering 
from GS2. 
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Figure legends 
 
Figure 1: Summary of the three different forms of GS (A); HLH = hemophagocytic 
lymphohistiocytosis; * = not present in a patient with Myo Va F-exon deletion. Patient 
with GS3 showing (A) the characteristic silvery gray sheen of the hair and eyelash, and 
(B) the characteristic large clump of pigment in the hair shaft observed by microscopic 
analysis.  
 
Figure 2 : (A) MLPH mutation in the patient. Detection of MLPH mutation was done by 
fluorometric sequencing. DNA sequence analysis of exon 7 showed a delC986 leading to 
L344X (homozygous for the patient). Mother and father are heterozygous for the base 
pair deletion. (B) Localization of the nonsense mutation on the schematic representation 
of melanophilin: Melanophilin is composed of three domain; a SHD domain (black box), 
a myosin binding domain (MBD)(hatched box) and an actin binding domain 
(ABD)(hatched box). The patient mutation L344X is located in the MBD domain. 
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